Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jubilant Ingrevia (BOM:543271) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Jubilant Ingrevia Forward PE Ratio Related Terms
Jubilant Ingrevia Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Jubilant Ingrevia's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Ingrevia Forward PE Ratio Chart
Jubilant Ingrevia Annual Data
Trend
2025-03
2026-03
Forward PE Ratio
29.14
23.20
Jubilant Ingrevia Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
40.15
29.14
34.03
32.30
28.78
23.20
26.11
BOM:543271 vs LIN, SHW, ECL: Forward PE Ratio Comparison
For the Specialty Chemicals subindustry, Jubilant Ingrevia's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jubilant Ingrevia Forward PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Jubilant Ingrevia's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Jubilant Ingrevia (BOM:543271) has a Forward PE Ratio of 29.82 as of Sep. 07, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Jubilant Ingrevia and its competitors. According to the industry distribution chart, Jubilant Ingrevia ranks #516 out of 665 companies in the Chemicals industry, placing it in the top 77.6%.
Is Jubilant Ingrevia's Forward PE Ratio too high?
Jubilant Ingrevia's current Forward PE Ratio is 29.82. The Chemicals industry median Forward PE Ratio is 15.81. Jubilant Ingrevia's value of 29.82 is 88.6% above this industry median. Based on the distribution chart, Jubilant Ingrevia ranks #516 out of 665 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Jubilant Ingrevia has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's Forward PE Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Jubilant Ingrevia ranks #516 out of 665 companies for Forward PE Ratio. This places Jubilant Ingrevia in the lower half of its industry. The industry median Forward PE Ratio is 15.81. Jubilant Ingrevia's value of 29.82 is 88.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Chemicals company?
The median Forward PE Ratio among Chemicals companies is 15.81, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jubilant Ingrevia's current Forward PE Ratio of 29.82 is 88.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Jubilant Ingrevia and its competitors. For the Chemicals industry, the median Forward PE Ratio is 15.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jubilant Ingrevia's current Forward PE Ratio is 29.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹760.64, compared to a current price of ₹681.15 — trading 10.5% below its estimated fair value. The current Forward PE Ratio is 29.82 and 88.6% above the Chemicals industry median of 15.81. Jubilant Ingrevia's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current Forward PE Ratio is 29.82 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?
Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued.
The current stock price of ₹681.15 is trading 10.5% below its estimated GF Value™ of ₹760.64.
GuruFocus considers Jubilant Ingrevia to be Modestly Undervalued.
Key valuation signals for BOM:543271:
Forward PE Ratio: 29.82
GF Value™: ₹760.64 vs. price of ₹681.15 (10.5% below fair value)
Industry Position: 88.6% above the Chemicals median (#516 of 665)
No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
82GF Score
Get the complete analysis for BOM:543271
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543271 has been successfully added to your 
